RESUMO
INTRODUCTION: Smoking tobacco results in the death of more than 8 million people every year. Our study aims to explore a new approach for smoking cessation by analyzing body composition differences between smokers and non-smokers, focusing on potential variations in biological and chronological ages. METHODS: A cross-sectional study was conducted in 2019 at the Special Hospital for Medical Rehabilitation in Croatia. It included 164 subjects, 81 smokers and 83 non-smokers, aged 40-65 years. This study was part of a two-year investigation on locomotor parameter changes as early COPD predictors. Measurements encompassed body parameters, spirometry tests, and body composition. Spirometry was done using the Flowscreen Pro device, and the FEV1/FVC ratio determined lung function. The GAIA 359 PLUS device assessed body composition and estimated biological age. Exclusion criteria applied to specific medical conditions and recent surgeries. RESULTS: Smokers had a slightly higher percentage of fat tissue than non-smokers (median=27%, IQR: 24-31) compared to non-smokers (median=25%, IQR: 22-28, p<0.001). The difference in the Gaia estimated age and the actual age of the subjects was significantly higher in the group of smokers (median=2, IQR: 0-3) compared to non-smokers (median=0 IQR: -2-2, p=0.003), but they did not differ in muscle tissue, weight or the proportion of trunk adipose tissue. CONCLUSIONS: Our study revealed that smokers exhibit higher fat tissue percentages and a higher estimated biological age relative to non-smokers. These findings underscore the established health hazards of smoking and the imperative for smoking cessation in mitigating these adverse effects.
RESUMO
BACKGROUND: Since the start of COVID pandemic, the Croatian government issued many recommendations and guidelines, imposed reorganization of health care system, and ordered two lock-downs to mitigate the spread of the disease. All of this may have had an unwanted effect on the standard of health care for non-COVID-19 patients, including children with neurological risk factors. OBJECTIVE: To highlight the possibility that measures taken to mitigate the COVID-19 pandemic may lead to a substantial delay of examination by physical medicine specialists and timely rehabilitation programs for children with neurological risks. DESIGN: A retrospective medical history-based study between 2020 and 2021. SETTING: The study was performed in Department of Physical and Rehabilitation Medicine at the University Hospital Centre of Split, Croatia. PATIENTS: Children with neurological risk examined by pediatric physical rehabilitation specialists in the Department of Physical and Rehabilitation Medicine between January 2017 and December 2021. METHODS: Case records of patients were reviewed, dividing them into groups according to severity of neurological risk and their age at the time of first examination. We also noted in what months of the year those examinations were performed. MAIN OUTCOME MEASUREMENTS: The outcome was change in the number of the first examinations and the age of the patients when the examination was first performed. RESULTS: During the pandemic year 2020, the total number of first examinations was lower by 244 (38%; 95% confidence interval [CI]: 34%-42%), and the number of first examinations of children with neurological risks was lower by 216 (36%; 95% CI: 33%-40%).On the contrary, in 2021, there was an increase in the total number of first examinations by 114 (18%; 95% CI: 15%-21%) and first examinations of children with neurological risks compared to the pre-pandemic years by 97 (16%; 95% CI: 13%-20%). Furthermore, the division of patients according to age at the time of first examination significantly differed in the pre-pandemic and pandemic 2021 periods (λ = 11.8; p = .018). The greatest contributing factor to this difference was the group of patients older than 12 months. CONCLUSIONS: The study suggests that the chaotic initial stages of the COVID-19 pandemic during 2020 caused delay in examinations by physical medicine specialists for children with neurological risks that could potentially affect neurodevelopmental outcomes.
